54868-3050 : Neupogen 480 ug/.8ml Intravenous Injection, Solution
NDC: | 54868-3050 |
Labeler: | Physicians Total Care, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Neupogen |
Dosage Form: | Intravenous Injection, Solution |
Application #: | BLA103353 |
Rev. Date: |
NDC Package Codes:
- 54868-3050-0: 10 SYRINGE IN 1 BOX (54868‑3050‑0) > .8 ML IN 1 SYRINGE
Active Ingredients:
- Filgrastim
Dosage Strength:
- 480 ug/.8mL
Pharmaceutical Classes:
- Granulocyte Colony-Stimulating Factor [Chemical/Ingredient]
- Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient]
- Increased Myeloid Cell Production [PE]
- Leukocyte Growth Factor [EPC]
Related Products:
Based on records with the same trade name.- 54868-2522 Neupogen 300 ug/ml Intravenous Injection, Solution by Physicians Total Care, Inc.
- 54868-5020 Neupogen 300 ug/.5ml Intravenous Injection, Solution by Physicians Total Care, Inc.
- 55513-209 Neupogen 480 ug/.8ml Intravenous; Subcutaneous Injection, Solution by Amgen Inc
- 55513-530 Neupogen 300 ug/ml Intravenous; Subcutaneous Injection, Solution by Amgen Inc
- 55513-546 Neupogen 480 ug/1.6ml Intravenous; Subcutaneous Injection, Solution by Amgen Inc
- 55513-924 Neupogen 300 ug/.5ml Intravenous; Subcutaneous Injection, Solution by Amgen Inc
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 54868-3049Next: 54868-3059 >
Related Discussions:
side effects,neupogen
stimulates white blood cells...
stimulates white blood cells...
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.